PIK3CA and invasive breast carcinoma: We analyzed in total 190 plasma‐ctDNA samples for PIK3CA hotspot mutations from (a) early BrCa (n = 77), (b) metastatic BrCa (n = 73), and (c) healthy donors (all female, n = 40).